Diabetic Retinopathy: all 791 studies
Page 8 of 8. Open to participants first (139), then studies with results posted, then the rest; newest registration first within each.
- Macular Appearance After Diabetic VitrectomyCompletedNCT00737022
- Fractalkine, a CX3C Chemokine, Act as a Mediator of Ocular AngiogenesisCompletedNCT00728598
- Diabetic Retinopathy and Sickle TraitCompletedNCT00720317
- Choroidal Blood Flow Changes During Dark/Light Transitions in Patients With Insulin-dependent Diabetes Mellitus (IDDM)TerminatedNCT00718614Not applicable
- Neurovascular Coupling in Patients With Early Stage Diabetes RetinopathyCompletedNCT00712842
- Evaluation of Retinal Changes in Systemic Darbepoetin Alpha Treatment in Patients With Diabetes MellitusTerminatedNCT00704652
- Intravitreal Bevacizumab for Diabetic Macular EdemaStatus unknownNCT00703235Phase 2/3
- Study Evaluating Efficacy and Safety of PF-04523655 Versus Laser in Subjects With Diabetic Macular EdemaTerminatedNCT00701181Phase 2
- Study on Tear Proteins in Diabetic Retinopathy of Type 2 DiabeticsStatus unknownNCT00698698
- Intravitreal Infliximab for Diabetic Macular Edema (DME) and Choroidal Neovascularization (CNV)Status unknownNCT00695682Phase 1
- Pars Plana Vitrectomy (PPV) Versus Preoperative Intravitreal Bevacizumab Plus PPV to Treat Diabetic Tractional Retinal Detachment (IBETRA)CompletedNCT00690768Phase 2
- Morphological and Functional Retinal Changes Following Retinal PhotocoagulationCompletedNCT00682240Phase 4
- Effects of Copaxone in the Retinal Function in Diabetic Patients After PanphotocoagulationStatus unknownNCT00677664Phase 4
- Intravitreal Injection of Bevacizumab and Gas for Diabetic Premacular Hemorrhage With Active Fibrovascular ProliferationStatus unknownNCT00673296Not applicable
- Safety and Tolerability of NOVA63035 "Corticosteroid" in Patients With Diabetic Macular Edema Secondary to Diabetic RetinopathyCompletedNCT00665106Phase 1
- A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy SubjectsTerminatedNCT00664183Phase 2/3
- Bevacizumab and Long Acting Gas in Diabetic VitrectomyCompletedNCT00656435Phase 3
- Genetics and Markers of Degenerative and Inflammatory Eye DiseasesCompletedNCT00647439
- Pharmacological Intervention in Diabetic RetinopathyCompletedNCT00619034Not applicable
- Intravitreal Bevacizumab for Diabetic RetinopathyTerminatedNCT00600262Phase 2/3
- HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican PopulationWithdrawnNCT00600236Phase 3
- Intravitreal Bevacizumab Pretreatment for Reducing Preretinal Hemorrhage in Diabetic VitrectomyCompletedNCT00596505
- Preoperative Bevacizumab for Vitreous HemorrhageCompletedNCT00596297Phase 1/2
- Anti-Nephropathic Effects of Chronic Intermittent Intravenous Insulin Therapy (CIIIT)CompletedNCT00594152Phase 3
- Changes in Macular Thickness After Patterns Scan LaserTerminatedNCT00563628Phase 4
- Changes in Electroretinogram and Contrast Sensitivity After PASCAL TreatmentTerminatedNCT00563043Phase 4
- Pars Plana Vitrectomy for Diabetic Fibrovascular Proliferation With and Without Internal Limiting Membrane PeelingStatus unknownNCT00556244Phase 1/2
- A Pilot Study of Functional Optical Coherence Tomography for Ocular ImagingCompletedNCT00556114
- Bevacizumab Versus Ranibizumab for Diabetic RetinopathyCompletedNCT00545870Phase 3
- Analgesic Effect of Etoricoxib (ARCOXIA®) 120MG During Retinal Laser PhotocoagulationCompletedNCT00529594Not applicable
- Effect of Intravitreal Bevacizumab on Early Post-Vitrectomy Hemorrhage in Diabetic PatientsStatus unknownNCT00524875Not applicable
- Evaluation of Ranibizumab in Proliferative Diabetic Retinopathy (PDR) Requiring VitrectomyStatus unknownNCT00516464Phase 3
- Treatment of Refractory Diabetic Macular Edema With InfliximabTerminatedNCT00505947Phase 3
- Diabetic Retinopathy and Diabetic Macular Edema Screening by Non-Physicians With Limited TrainingCompletedNCT00500097Not applicable
- Determining Rates of Cardiovascular Complications Among Patients of a Managed Diabetes Care ProgramStatus unknownNCT00498147
- Unilateral Bevacizumab for Bilateral Diabetic Macular EdemaWithdrawnNCT00496405Phase 4
- Intravitreal Triamcinolone Acetonide for Diabetic Macular EdemaStatus unknownNCT00476918Phase 1
- A Phase 2 Study Exploring The Safety And Efficacy Of Novel Drug Treatment In Subjects With Diabetic Macular Edema (DME)WithdrawnNCT00457470Phase 2
- Effect of Macugen(Pegaptanib)on Surgical Outcomes and VEGF Levels in Diabetic Patients With PDR (Diabetic Retinopathy or CSDME (Macular Edema)CompletedNCT00446381Not applicable
- Triamcinolone as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic RetinopathyCompletedNCT00443521Phase 2/3
- The Course of Response to Focal Photocoagulation for DMECompletedNCT00442156
- Intravitreal Bevacizumab for Proliferative Diabetic RetinopathyCompletedNCT00423059Not applicable
- A Phase 1 Safety Study of TG100801 Eye Drops in Healthy VolunteersCompletedNCT00414999Phase 1
- 20- Versus 23- Gauge System for Pars Plana VitrectomyCompletedNCT00411970Phase 4
- Vascular Remodeling and the Effects of Angiogenic Inhibition in Diabetic RetinopathyCompletedNCT00411333Early Phase 1
- Intravitreal Triamcinolone Acetonide for Treatment of Refractory Diffuse Diabetic Macular EdemaStatus unknownNCT00407849Phase 1/2
- Perfluorocarbon Perfused Vitrectomy and 3D Vitrectomy System in Advanced Diabetic RetinopathyWithdrawnNCT00407108Phase 3
- Retinal Blood Flow and Microthrombi in Type 1 DiabetesCompletedNCT00406991Phase 2
- Clinical and Pathophysiological Description of Ocular Ischemic SyndromeCompletedNCT00403195
- Intravitreal Bevacizumab for Retinal DisordersStatus unknownNCT00403026Not applicable
- Safety and Tolerability of MS-R001 in Patients With Diabetic Macular Edema Secondary to Diabetic RetinopathyCompletedNCT00401115Phase 1
- Efficacy Study of Lucentis in the Treatment of Diabetic Macular EdemaCompletedNCT00387582Phase 2
- Metabolic Mapping to Measure Retinal MetabolismCompletedNCT00385333Phase 2
- Intravitreal Bevacizumab for Management of Active Progressive Proliferative Diabetic Retinopathy (PDR)Status unknownNCT00370721Phase 3
- Green Laser Photocoagulation Study in Proliferative Diabetic RetinopathyCompletedNCT00355680Phase 3
- Intravitreal Bevacizumab vs Photocoagulation for Proliferative Diabetic RetinopathyWithdrawnNCT00347698Phase 2/3
- Tracking Optical Coherence TomographyCompletedNCT00343603
- The Effect of Amlodipine and Lisinopril on Retinal Autoregulation in Type 1 DiabetesCompletedNCT00337298Not applicable
- A Pilot Study for the Treatment of Iris Neovascularization With MacugenCompletedNCT00295828Phase 1
- Effects of Pulsatile IV Insulin Delivery on Diabetic Retinopathy in Patients With Types 1 and 2 Diabetes MellitusTerminatedNCT00287651Phase 2/3
- Extension Study of the Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic RetinopathyTerminatedNCT00248157Phase 3
- Extension Study of Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic RetinopathyTerminatedNCT00248131Phase 3
- Triamcinolone Acetonide Injections to Treat Diabetic Macular EdemaCompletedNCT00231023Phase 2
- PST/Laser v. Laser Alone for CSMEStatus unknownNCT00229918Phase 2
- Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.).TerminatedNCT00211471Phase 2
- Treatment of Diabetic Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg)TerminatedNCT00211406Phase 1
- Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous HemorrhageCompletedNCT00198510Phase 3
- Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous HemorrhageCompletedNCT00198497Phase 3
- Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous DetachmentCompletedNCT00198471Phase 2
- Comparison of Insulin Glargine and NPH Human Insulin in Progression of Diabetic Retinopathy in Type 2 Diabetic PatientsCompletedNCT00174824Phase 4
- Study to Assess the Efficacy and Safety of Monthly Octreotide Intramuscular Injections in Patients With Proliferative Diabetic Retinopathy After Lasercoagulation This Study is Not Being Conducted in the United States.TerminatedNCT00170742Phase 3
- Intravitreal Long Acting Gas in the Prevention of Early Postoperative Vitreous Hemorrhage in Diabetic VitrectomyCompletedNCT00155454Not applicable
- Octreotide Acetate in Microspheres in Patients With Diabetic RetinopathyCompletedNCT00131144Phase 3
- Octreotide Acetate in Microspheres in Patients With Diabetic RetinopathyCompletedNCT00130845Phase 3
- Study to Evaluate the Effectiveness of a Program Developed to Improve Eye Care for Veterans With DiabetesCompletedNCT00119535Not applicable
- Treatment of Diabetic Macular Edema: Triamcinolone Injections Vs. Laser PhotocoagulationCompletedNCT00105404Phase 3
- Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal DisordersCompletedNCT00101764Phase 1
- Pilot Study of Laser Photocoagulation Therapy for Diabetic Macular EdemaCompletedNCT00069056Phase 1
- Multi-Ethnic Study of Atherosclerosis (MESA) - Ancillary Eye StudyCompletedNCT00041444
- Research Study in Patients With Persistent Macular EdemaCompletedNCT00035906Phase 2
- Blood Factors and Diabetic RetinopathyCompletedNCT00005761
- Screening for Studies on Retinovascular DiseasesCompletedNCT00001733
- Long-Term Follow-Up of Patients Enrolled in the Early Treatment Diabetic Retinopathy Study (ETDRS)CompletedNCT00001612
- Long Term Follow-Up of Diabetic RetinopathyCompletedNCT00001395
- Diabetic Retinopathy and Visual Function StudyCompletedNCT00001346
- Tissue Studies of Human Eye DiseasesTerminatedNCT00001310
- Diabetic Retinopathy Study (DRS)CompletedNCT00000160Phase 3
- Sorbinil Retinopathy Trial (SRT)CompletedNCT00000159Phase 3
- Diabetic Retinopathy Vitrectomy Study (DRVS)CompletedNCT00000154Phase 3
- Krypton-Argon Regression of Neovascularization Study (KARNS)CompletedNCT00000153Phase 3
- Early Treatment Diabetic Retinopathy Study (ETDRS)CompletedNCT00000151Phase 3